These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3896970

  • 1. Monoclonal antibodies and immunotoxins in bone marrow transplantation: purging marrow of ALL or GVHD cells with preservation of stem cells.
    Kersey JH, Vallera D, Ramsay N, Filipovich A, Youle R, Neville D, Stong R, LeBien T.
    Haematol Blood Transfus; 1985; 29():34-8. PubMed ID: 3896970
    [No Abstract] [Full Text] [Related]

  • 2. Bone marrow purging using monoclonal antibodies.
    Ramsay NK, Kersey JH.
    J Clin Immunol; 1988 Mar; 8(2):81-8. PubMed ID: 3286676
    [No Abstract] [Full Text] [Related]

  • 3. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
    Uckun FM, Stong RC, Youle RJ, Vallera DA.
    J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712
    [Abstract] [Full Text] [Related]

  • 4. T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease.
    Fauser AA, Shustik C, Langleben A, Laurent G, Kanz L, Spurll GM, Price G, Ahlgren PD, Cooper BA.
    Clin Invest Med; 1988 Feb; 11(1):40-6. PubMed ID: 3284672
    [Abstract] [Full Text] [Related]

  • 5. Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma.
    Preijers FW, De Witte T, Wessels JM, De Gast GC, Van Leeuwen E, Capel PJ, Haanen C.
    Blood; 1989 Aug 15; 74(3):1152-8. PubMed ID: 2473811
    [Abstract] [Full Text] [Related]

  • 6. In vitro treatment of bone marrow from patients with T-cell acute lymphoblastic leukemia and non-Hodgkin's lymphoma using the immunotoxin WT1-ricin A.
    Barnett MJ, Rohatiner AZ, Kingston JE, Adams KE, Batten EL, Bassan R, Thorpe PE, Horton MA, Malpas JS, Lister TA.
    Haematol Blood Transfus; 1987 Aug 15; 31():57-8. PubMed ID: 3327786
    [No Abstract] [Full Text] [Related]

  • 7. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
    Ramakrishnan S, Uckun FM, Houston LL.
    J Immunol; 1985 Nov 15; 135(5):3616-22. PubMed ID: 3900212
    [Abstract] [Full Text] [Related]

  • 8. Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin): effective prophylaxis for graft-versus-host disease.
    Antin JH, Bierer BE, Smith BR, Guinan EC, Provost MM, Ferrara J, Macklis RM, Tarbell NJ, Blythman H, Bouloux C.
    Prog Clin Biol Res; 1990 Nov 15; 333():207-15. PubMed ID: 1689852
    [No Abstract] [Full Text] [Related]

  • 9. Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease.
    Filipovich AH, Vallera DA, Youle RJ, Quinones RR, Neville DM, Kersey JH.
    Lancet; 1984 Mar 03; 1(8375):469-72. PubMed ID: 6142206
    [Abstract] [Full Text] [Related]

  • 10. Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow.
    Quinones RR, Youle RJ, Kersey JH, Zanjani ED, Azemove SM, Soderling CC, Lebien TW, Beverley PC, Neville DM, Vallera DA.
    J Immunol; 1984 Feb 03; 132(2):678-83. PubMed ID: 6606676
    [Abstract] [Full Text] [Related]

  • 11. An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin A.
    Myers CD, Thorpe PE, Ross WC, Cumber AJ, Katz FE, Tax W, Greaves MF.
    Blood; 1984 May 03; 63(5):1178-85. PubMed ID: 6370334
    [Abstract] [Full Text] [Related]

  • 12. Bone marrow purging with immunotoxins for treatment of T cell acute lymphoblastic leukemia (T-ALL).
    Vallera DA, Uckun FM.
    Prog Clin Biol Res; 1990 May 03; 333():191-204; discussion 205. PubMed ID: 2308981
    [No Abstract] [Full Text] [Related]

  • 13. The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies.
    Macintyre EA.
    Clin Haematol; 1986 Feb 03; 15(1):249-67. PubMed ID: 3516492
    [No Abstract] [Full Text] [Related]

  • 14. Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation.
    Stong RC, Uckun F, Youle RJ, Kersey JH, Vallera DA.
    Blood; 1985 Sep 03; 66(3):627-35. PubMed ID: 3896347
    [Abstract] [Full Text] [Related]

  • 15. 'Purging' of bone marrow and immunosuppression.
    Janossy G.
    Br Med Bull; 1984 Jul 03; 40(3):247-53. PubMed ID: 6380636
    [No Abstract] [Full Text] [Related]

  • 16. Bone-marrow purging with monoclonal antibodies and human complement in ALL and AML.
    Majdic O, Sugita K, Touw I, Köller U, Stockinger H, Delwel R, Löwenberg B, Knapp W.
    Haematol Blood Transfus; 1987 Jul 03; 31():86-8. PubMed ID: 3327791
    [No Abstract] [Full Text] [Related]

  • 17. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow.
    Filipovich AH, Vallera DA, Youle RJ, Haake R, Blazar BR, Arthur D, Neville DM, Ramsay NK, McGlave P, Kersey JH.
    Transplantation; 1987 Jul 03; 44(1):62-9. PubMed ID: 3299923
    [Abstract] [Full Text] [Related]

  • 18. Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: efficacy of ex vivo treatment with immunotoxins and 4-hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells.
    Uckun FM, Gajl-Peczalska K, Meyers DE, Ramsay NC, Kersey JH, Colvin M, Vallera DA.
    Blood; 1987 Jan 03; 69(1):361-6. PubMed ID: 3098325
    [Abstract] [Full Text] [Related]

  • 19. Anti-T-cell reagents for human bone marrow transplantation: ricin linked to three monoclonal antibodies.
    Vallera DA, Ash RC, Zanjani ED, Kersey JH, LeBien TW, Beverley PC, Neville DM, Youle RJ.
    Science; 1983 Nov 04; 222(4623):512-5. PubMed ID: 6353579
    [Abstract] [Full Text] [Related]

  • 20. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
    Koehler M, Hurwitz CA, Krance RA, Coustan-Smith E, Williams LL, Santana V, Ribeiro RC, Brenner MK, Heslop HE.
    Bone Marrow Transplant; 1994 May 04; 13(5):571-5. PubMed ID: 7519937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.